Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Biological markers associated to increased coronary artery calcifications after adjustment for age, gender, diabetes mellitus and smoking (the p-value of the test for trend is given). | Coronary artery calcifications | | Coronary artery calcifications | | <100 (n = 79) | [100 to 400[ (n = 50) | ≥400 (n = 66) | | [100 to 400[ vs <100 | ≥400 vs <100 | Variable | n | % | n | % | n | % | Global P-value | OR [CI 95%] | OR [CI 95%]: 1.25 (OH)2 vitamin D (pg/mL) | | | | | | | | |

Source: Results table. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

195 ND-CKD patients (112 males/83 females, 70.8 [27.4 to 94.6] years) were enrolled in this cross-sectional study.

Source: Abstract.

In the case of FGF23 and OPG, patients were divided into two categories, those with a low level (<173.30 RU/mL for FGF23; <10.71 pmol/L for OPG, corresponding to the 1st and 2nd tertiles) and those with a high level (≥173.30 RU/mL for FGF23; ≥10.71 pmol/L for OPG, corresponding to the 3rd tertile).

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Bone Biomarkers Help Grading Severity of Coronary Calcifications in Non Dialysis Chronic Kidney Disease Patients

Cross-sectional study · PLoS ONE · 2012

Original publication title

Bone Biomarkers Help Grading Severity of Coronary Calcifications in Non Dialysis Chronic Kidney Disease Patients

Marion Morena; Isabelle Jaussent; Aurore Halkovich; Anne-Marie Dupuy; Anne-Sophie Bargnoux; Leila Chenine; Hélène Leray-Moragues; Kada Klouche; Hélène Vernhet; Bernard Canaud; Jean-Paul Cristol

Morena et al.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Our results strongly suggest that OPG is associated to moderate CAC while FGF23 rather represents a biomarker of severe CAC in ND-CKD patients.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Osteoprotegerin (OPG) and fibroblast growth factor-23 (FGF23) are recognized as strong risk factors of vascular calcifications in non dialysis chronic kidney disease (ND-CKD) patients. The aim of this study was to investigate the relationships between FGF23, OPG, and coronary artery calcifications (CAC) in this population and to attempt identification of the most powerful biomarker of CAC: FGF23? OPG?

Source: Background

Abstract: Methodology/Principal Findings

195 ND-CKD patients (112 males/83 females, 70.8 [27.4 to 94.6] years) were enrolled in this cross-sectional study. All underwent chest multidetector computed tomography for CAC scoring. Vascular risk markers including FGF23 and OPG were measured. Logistic regression analyses were used to study the potential relationships between CAC and these markers.

The fully adjusted-univariate analysis clearly showed high OPG (≥10.71 pmol/L) as the only variable significantly associated with moderate CAC ([100 to 400[) (OR = 2.73 [1.03;7.26]; p = 0.04). Such association failed to persist for CAC scoring higher than 400. Indeed, severe CAC was only associated with high phosphate fractional excretion (FEPO4) (≥38.71%) (OR = 5.47 [1.76;17.0]; p = 0.003) and high FGF23 (≥173.30 RU/mL) (OR = 5.40 [1.91;15.3]; p = 0.002). In addition, the risk to present severe CAC when FGF23 level was high was not significantly different when OPG was normal or high.

Conversely, the risk to present moderate CAC when OPG level was high was not significantly different when FGF23 was normal or high.

Source: Methodology/Principal Findings Source: Methodology/Principal Findings

Abstract: Conclusions

Our results strongly suggest that OPG is associated to moderate CAC while FGF23 rather represents a biomarker of severe CAC in ND-CKD patients.

Source: Conclusions
Authors’ abstract

Background

Osteoprotegerin (OPG) and fibroblast growth factor-23 (FGF23) are recognized as strong risk factors of vascular calcifications in non dialysis chronic kidney disease (ND-CKD) patients. The aim of this study was to investigate the relationships between FGF23, OPG, and coronary artery calcifications (CAC) in this population and to attempt identification of the most powerful biomarker of CAC: FGF23? OPG?

Methodology/Principal Findings

195 ND-CKD patients (112 males/83 females, 70.8 [27.4 to 94.6] years) were enrolled in this cross-sectional study. All underwent chest multidetector computed tomography for CAC scoring. Vascular risk markers including FGF23 and OPG were measured. Logistic regression analyses were used to study the potential relationships between CAC and these markers.

The fully adjusted-univariate analysis clearly showed high OPG (≥10.71 pmol/L) as the only variable significantly associated with moderate CAC ([100 to 400[) (OR = 2.73 [1.03;7.26]; p = 0.04). Such association failed to persist for CAC scoring higher than 400. Indeed, severe CAC was only associated with high phosphate fractional excretion (FEPO4) (≥38.71%) (OR = 5.47 [1.76;17.0]; p = 0.003) and high FGF23 (≥173.30 RU/mL) (OR = 5.40 [1.91;15.3]; p = 0.002). In addition, the risk to present severe CAC when FGF23 level was high was not significantly different when OPG was normal or high.

Conversely, the risk to present moderate CAC when OPG level was high was not significantly different when FGF23 was normal or high.

Conclusions

Our results strongly suggest that OPG is associated to moderate CAC while FGF23 rather represents a biomarker of severe CAC in ND-CKD patients.

Publication and source details

Original title: Bone Biomarkers Help Grading Severity of Coronary Calcifications in Non Dialysis Chronic Kidney Disease Patients

Marion Morena; Isabelle Jaussent; Aurore Halkovich; Anne-Marie Dupuy; Anne-Sophie Bargnoux; Leila Chenine; Hélène Leray-Moragues; Kada Klouche; Hélène Vernhet; Bernard Canaud; Jean-Paul Cristol

PLoS ONE · 2012

* E-mail: jp-cristol@chu-montpellier.fr

Conceived and designed the experiments: MM AMD KK HV BC JPC. Performed the experiments: MM AH AMD ASB LC HLM KK HV BC JPC. Analyzed the data: MM IJ AMD BC JPC . Wrote the paper: MM IJ BC JPC . Reviewed, revised and approved the final paper: MM IJ AH AMD ASB LC HLM KK HV BC JPC.

Morena et al.2012https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T21:10:36.371533+00:00

DOI: 10.1371/journal.pone.0036175 · PMC3342257